Filing Details
- Accession Number:
- 0001209191-13-048236
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-10-11 17:40:01
- Reporting Period:
- 2013-10-10
- Filing Date:
- 2013-10-11
- Accepted Time:
- 2013-10-11 17:40:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
786947 | Acura Pharmaceuticals Inc | ACUR | Pharmaceutical Preparations (2834) | 110853640 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1034486 | P L Iii Partners Galen | C/O Galen Management, L.l.c. 680 Washington Blvd. Stamford CT 06901 | No | No | Yes | No | |
1034574 | P L Iii International Partners Galen | C/O Galen Management, L.l.c. 680 Washington Blvd. Stamford CT 06901 | No | No | Yes | No | |
1056642 | Galen Employee Fund Iii Lp | C/O Galen Management L.l.c. 680 Washington Blvd. Stamford CT 06901 | No | No | Yes | No | |
1056643 | Claudius Llc | C/O Galen Management, L.l.c. 680 Washington Blvd. Stamford CT 06901 | No | No | Yes | No | |
1421162 | Galen Management, Llc | 680 Washington Blvd. Stamford CT 06901 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-10-10 | 4,200 | $2.05 | 11,528,598 | No | 4 | S | Indirect | See FN |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See FN |
Footnotes
- The shares were sold as follows: 3,837 by Galen Partners III, L.P. ("Galen III"), 347 by Galen Partners International III, L.P. ("Galen International") and 16 by Galen Employee Fund III, L.P. ("Employee Fund").
- The shares are held as follows: 10,535,082 by Galen III, 950,122 by Galen International and 43,394 by Employee Fund. Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Galen Management, L.L.C. serves as the sole General Partner of Employee Fund and has sole voting and investment control over the shares held by Employee Fund and may be deemed to beneficially own the shares held by Employee Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.